Latest News in the pharma Industry

Policy & Regulation

CHMP Grants Actavis' Subsidiary Durata Therapeutics International, a Positive Opinion for Xydalba  for the Treatment of ABSSSI in Adults.

CHMP Grants Actavis' Subsidiary Durata Therapeutics International, a Positive Opinion for Xydalba for the Treatment of ABSSSI in Adults.

22 Dec 2014

Read more 
Successful FDA Inspection at Hovione

Successful FDA Inspection at Hovione

18 Dec 2014

Read more 
Rx-360 Summary of FDA’s Draft Guidance for Industry DSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs

Rx-360 Summary of FDA’s Draft Guidance for Industry DSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs

18 Dec 2014

Read more 
Janssen Launches Imbruvica, First-in-Class Treatment for Patients with CLL and MCL in UK

Janssen Launches Imbruvica, First-in-Class Treatment for Patients with CLL and MCL in UK

17 Dec 2014

Read more 
Lilly's Cyramza (ramucirumab) Receives Third FDA Approval

Lilly's Cyramza (ramucirumab) Receives Third FDA Approval

17 Dec 2014

Read more 
Novartis Gains FDA Approval for Signifor LAR to Treat Patients with Acromegaly

Novartis Gains FDA Approval for Signifor LAR to Treat Patients with Acromegaly

16 Dec 2014

Read more 
Adults Living with Ulcerated Colitis Will Have Treatment Option of AbbVie’s Anti-TNF Humira

Adults Living with Ulcerated Colitis Will Have Treatment Option of AbbVie’s Anti-TNF Humira

15 Dec 2014

Read more 
FDA Approves Merck's HPV Vaccine, Gardasil 9

FDA Approves Merck's HPV Vaccine, Gardasil 9

12 Dec 2014

Read more 
GVK Biosciences Review: Some Member States Suspend Marketing Authorisations for Concerned Medicines

GVK Biosciences Review: Some Member States Suspend Marketing Authorisations for Concerned Medicines

8 Dec 2014

Read more 
FDA Issues Guidance Helping Manufacturers Gain Access to REMS Drugs for Generic Development?

FDA Issues Guidance Helping Manufacturers Gain Access to REMS Drugs for Generic Development?

5 Dec 2014

Read more 
Mylan Receives Tentative FDA approval for Paediatric Formulations of Abacavir/Lamivudine Through Innovative Collaboration

Mylan Receives Tentative FDA approval for Paediatric Formulations of Abacavir/Lamivudine Through Innovative Collaboration

5 Dec 2014

Read more 
FDA Approves Amgen's Blincyto (Blinatumomab) Immunotherapy

FDA Approves Amgen's Blincyto (Blinatumomab) Immunotherapy

4 Dec 2014

Read more